AT354632B - PROCESS FOR PRODUCING A FACTOR VIII CONCENTRATE - Google Patents

PROCESS FOR PRODUCING A FACTOR VIII CONCENTRATE

Info

Publication number
AT354632B
AT354632B AT53277A AT53277A AT354632B AT 354632 B AT354632 B AT 354632B AT 53277 A AT53277 A AT 53277A AT 53277 A AT53277 A AT 53277A AT 354632 B AT354632 B AT 354632B
Authority
AT
Austria
Prior art keywords
producing
factor viii
viii concentrate
concentrate
factor
Prior art date
Application number
AT53277A
Other languages
German (de)
Other versions
ATA53277A (en
Inventor
Edward Shanbrom
Original Assignee
Recherches Hematologiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/653,973 external-priority patent/US4069216A/en
Application filed by Recherches Hematologiques filed Critical Recherches Hematologiques
Application granted granted Critical
Publication of AT354632B publication Critical patent/AT354632B/en
Publication of ATA53277A publication Critical patent/ATA53277A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
AT53277A 1976-01-30 1977-01-28 PROCESS FOR PRODUCING A FACTOR VIII CONCENTRATE AT354632B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/653,973 US4069216A (en) 1975-06-16 1976-01-30 Simplified methods for preparation of very high purity Factor VIII concentrate

Publications (2)

Publication Number Publication Date
AT354632B true AT354632B (en) 1979-01-25
ATA53277A ATA53277A (en) 1979-06-15

Family

ID=24623016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT53277A AT354632B (en) 1976-01-30 1977-01-28 PROCESS FOR PRODUCING A FACTOR VIII CONCENTRATE

Country Status (16)

Country Link
JP (1) JPS52102410A (en)
AR (1) AR214625A1 (en)
AT (1) AT354632B (en)
BE (1) BE850852A (en)
BR (1) BR7700554A (en)
CA (1) CA1101332A (en)
DE (1) DE2703620C2 (en)
DK (1) DK146855C (en)
ES (1) ES455473A1 (en)
FR (1) FR2339621A1 (en)
GB (1) GB1557609A (en)
LU (1) LU76652A1 (en)
MX (1) MX5197E (en)
NL (1) NL179290C (en)
NO (1) NO145563C (en)
SE (1) SE442953B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE448945B (en) * 1979-12-20 1987-03-30 Blombaeck E G B PROCEDURE FOR CLEANING AND / OR CONCENTRATION OF THE FACTOR VIII COMPLEX
AT369263B (en) * 1980-08-27 1982-12-27 Immuno Ag METHOD FOR PRODUCING A FACTOR VIII (AHF) HIGH CONCENTRATE
DE3279292D1 (en) * 1981-04-08 1989-01-26 Atomic Energy Authority Uk Blood fractionation improvement
US4382028A (en) * 1982-07-19 1983-05-03 Monsanto Company Separation of plasma proteins from cell culture systems
FR2535173A1 (en) * 1982-11-03 1984-05-04 Protein Sa Products obtained from the blood of abattoir animals and method for obtaining them.
FR2603805A1 (en) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl PROCESS FOR THE INACTIVATION BY OZONOLYSIS OF CONTAMINANT MICROORGANISMS PRESENT IN ESSENTIALLY PROTECTED BIOLOGICAL MATERIALS, THE PRODUCTS OBTAINED AND THEIR BIOLOGICAL AND ANALYTICAL APPLICATIONS
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
ES2674071T3 (en) 2012-06-26 2018-06-27 Conwed Plastics Llc Membrane filtration using a low energy food spacer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (en) * 1962-01-03
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US3839314A (en) * 1971-06-29 1974-10-01 Baxter Laboratories Inc Clarification of blood serum and plasma using block copolymers of ethylene oxide and polyoxypropylene
US3770631A (en) * 1971-06-29 1973-11-06 Baxter Laboratories Inc Clarification of blood serum and plasma
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3893990A (en) * 1973-04-05 1975-07-08 Baxter Laboratories Inc Clarification of blood serum and plasma using a block copolymer of ethylene oxide and polyoxypropylene

Also Published As

Publication number Publication date
DE2703620A1 (en) 1977-08-04
NL179290C (en) 1986-08-18
FR2339621B1 (en) 1980-06-06
BR7700554A (en) 1977-10-04
SE7700864L (en) 1977-07-31
DK146855C (en) 1984-07-02
MX5197E (en) 1983-04-25
FR2339621A1 (en) 1977-08-26
NO145563C (en) 1982-04-21
GB1557609A (en) 1979-12-12
ES455473A1 (en) 1978-01-01
AR214625A1 (en) 1979-07-13
JPS6242887B2 (en) 1987-09-10
ATA53277A (en) 1979-06-15
JPS52102410A (en) 1977-08-27
DK36477A (en) 1977-07-31
CA1101332A (en) 1981-05-19
NL179290B (en) 1986-03-17
SE442953B (en) 1986-02-10
NO145563B (en) 1982-01-11
BE850852A (en) 1977-07-28
LU76652A1 (en) 1978-09-13
NL7700927A (en) 1977-08-02
DE2703620C2 (en) 1984-11-22
DK146855B (en) 1984-01-23
NO770293L (en) 1977-08-02

Similar Documents

Publication Publication Date Title
DD133519A5 (en) METHOD FOR PRODUCING A PROJECT ASSOCIATION
ATA102477A (en) METHOD FOR PRODUCING A RETRORE-REFLECTING COATING MATERIAL
DD132052A5 (en) PROCESS FOR PREPARING A CATALYST
AT369429B (en) METHOD FOR PRODUCING A PARTLY REDUCED PRODUCT
AT355238B (en) METHOD FOR PRODUCING A NEW HENTRIA CONTAPEPTIDE
DD132786A5 (en) METHOD FOR PRODUCING A NEW OXIMAETHER
AT370397B (en) METHOD FOR PRODUCING A LIGHTWEIGHT MATERIAL
AT362221B (en) METHOD FOR PRODUCING A FOOD OR FEED
ATA320277A (en) METHOD FOR PRODUCING A NINE VINCAMINE SALT
AT351003B (en) METHOD FOR PRODUCING A CATALYST FOR THE PRESENT DISPLAY
AT369263B (en) METHOD FOR PRODUCING A FACTOR VIII (AHF) HIGH CONCENTRATE
AT357407B (en) METHOD FOR PRODUCING A BACON-LIKE PRODUCT
AT360512B (en) METHOD FOR PRODUCING A D-ENANTIOMERIC INDOLDER DERIVATIVE
DD131019A5 (en) PROCESS FOR THE PREPARATION OF A 2-DESOXYSTREPTAMINAMINOGLYCOSIDE
ATA53277A (en) PROCESS FOR PRODUCING A FACTOR VIII CONCENTRATE
ATA499079A (en) METHOD FOR PRODUCING A SYNTHETIC CREPEGARN
PT65720B (en) PROCESS FOR PREPARING A HERBICIDE
AT351493B (en) PROCESS FOR PRODUCING A NEW LEAD MONOXIDE
AT366056B (en) METHOD FOR PRODUCING A PHOSPHOROUS DICHLORIDOTHIOLATE
AT358723B (en) METHOD FOR PRODUCING A LIPASY ENCYMPREPAIR
AT335485B (en) METHOD FOR PRODUCING A UREA-FORMALDEHYDE DUNGER
AT362214B (en) METHOD FOR PRODUCING A LAMINATE
ATA136678A (en) PROCESS FOR PRODUCING A NEW MORPHANDERIVATE
AT361527B (en) METHOD FOR PRODUCING A COMPOSITE
DD133672A5 (en) METHOD FOR PRODUCING A SAEURE ADDITIONAL SALT

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
UEP Publication of translation of european patent specification
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee